Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah K Dutcher

Showing results (1-10 of 54) with videos related to

Pageof 6
Sort By:
JAMA|December 27, 2022
COVID-19 vs Influenza for Risk of Thrombotic Events in Hospitalized Patients-ReplyVincent Lo Re, Sarah K Dutcher, Noelle M Cocoros
Pharmacoepidemiology and Drug Safety|November 7, 2019
Using real-world data to evaluate biosimilar switchingSarah K Dutcher, Efe Eworuke, Michael D Blum, et al.
The Annals of Pharmacotherapy|April 21, 2017
Provider and Patient Determinants of Generic Levothyroxine Prescribing: An Electronic Health Records-Based StudyRobert J Romanelli, Vani Nimbal, Sarah K Dutcher, et al.
Nitric Oxide : Biology and Chemistry|November 21, 2007
Oxidation of 5-thio-2-nitrobenzoic acid, by the biologically relevant oxidants peroxynitrite anion, hydrogen peroxide and hypochlorous acidLisa M Landino, Catherine B Mall, Joshua J Nicklay, et al.
The International Journal of Biostatistics|June 17, 2026
Targeted maximum likelihood estimation (TMLE) in regulatory submissions and research: a landscape analysisHana Lee, Menglun Wang, Spencer Haupert, et al.
Journal of General Internal Medicine|June 1, 2022
Uptake and Competition Among Biosimilar Biological Products in the US Medicare Fee-for-Service PopulationSteven Kozlowski, Natasha Flowers, Andrew Kwist, et al.
Research in Social & Administrative Pharmacy : RSAP|April 23, 2011
Medication reconciliation during the transition to and from long-term care settings: a systematic reviewPankdeep T Chhabra, Gail B Rattinger, Sarah K Dutcher, et al.
Cell Cycle (Georgetown, Tex.)|February 2, 2008
PolyHEMA spheroids are an inadequate model for the drug resistance of the intractable solid tumorsKenneth Steadman, Wilfred D Stein, Thomas Litman, et al.
Therapeutic Innovation & Regulatory Science|February 3, 2020
Determinants of Generic Drug Substitution in the United StatesJodi B Segal, Oluwadamilola Onasanya, Matthew Daubresse, et al.
Clinical Pharmacology and Therapeutics|November 23, 2017
Generic Versions of Narrow Therapeutic Index Drugs: A National Survey of Pharmacists' Substitution Beliefs and PracticesAmeet Sarpatwari, Moa P Lee, Joshua J Gagne, et al.
Pageof 6

Showing results (1-10 of 54) with videos related to

Sort By:
Pageof 6
JAMA|December 27, 2022
COVID-19 vs Influenza for Risk of Thrombotic Events in Hospitalized Patients-ReplyVincent Lo Re, Sarah K Dutcher, Noelle M Cocoros
Pharmacoepidemiology and Drug Safety|November 7, 2019
Using real-world data to evaluate biosimilar switchingSarah K Dutcher, Efe Eworuke, Michael D Blum, et al.
The Annals of Pharmacotherapy|April 21, 2017
Provider and Patient Determinants of Generic Levothyroxine Prescribing: An Electronic Health Records-Based StudyRobert J Romanelli, Vani Nimbal, Sarah K Dutcher, et al.
Nitric Oxide : Biology and Chemistry|November 21, 2007
Oxidation of 5-thio-2-nitrobenzoic acid, by the biologically relevant oxidants peroxynitrite anion, hydrogen peroxide and hypochlorous acidLisa M Landino, Catherine B Mall, Joshua J Nicklay, et al.
The International Journal of Biostatistics|June 17, 2026
Targeted maximum likelihood estimation (TMLE) in regulatory submissions and research: a landscape analysisHana Lee, Menglun Wang, Spencer Haupert, et al.
Journal of General Internal Medicine|June 1, 2022
Uptake and Competition Among Biosimilar Biological Products in the US Medicare Fee-for-Service PopulationSteven Kozlowski, Natasha Flowers, Andrew Kwist, et al.
Research in Social & Administrative Pharmacy : RSAP|April 23, 2011
Medication reconciliation during the transition to and from long-term care settings: a systematic reviewPankdeep T Chhabra, Gail B Rattinger, Sarah K Dutcher, et al.
Cell Cycle (Georgetown, Tex.)|February 2, 2008
PolyHEMA spheroids are an inadequate model for the drug resistance of the intractable solid tumorsKenneth Steadman, Wilfred D Stein, Thomas Litman, et al.
Therapeutic Innovation & Regulatory Science|February 3, 2020
Determinants of Generic Drug Substitution in the United StatesJodi B Segal, Oluwadamilola Onasanya, Matthew Daubresse, et al.
Clinical Pharmacology and Therapeutics|November 23, 2017
Generic Versions of Narrow Therapeutic Index Drugs: A National Survey of Pharmacists' Substitution Beliefs and PracticesAmeet Sarpatwari, Moa P Lee, Joshua J Gagne, et al.
Pageof 6